1,385
Participants
Start Date
July 31, 2006
Primary Completion Date
April 30, 2008
Study Completion Date
April 30, 2008
flibanserin
Experimental: flibanserin 25 mg b.i.d
flibanserin
Experimental: flibanserin 50mg qhs
flibanserin
Experimental: flibanserin 50mg b.i.d.
placebo
placebo
511.70.01068 Boehringer Ingelheim Investigational Site, Huntsville
511.70.01040 Boehringer Ingelheim Investigational Site, Mobile
511.70.01041 Boehringer Ingelheim Investigational Site, Tucson
511.70.01003 Boehringer Ingelheim Investigational Site, Jonesboro
511.70.01070 Boehringer Ingelheim Investigational Site, Carmichael
511.70.01026 Boehringer Ingelheim Investigational Site, Redding
511.70.01015 Boehringer Ingelheim Investigational Site, San Diego
511.70.01014 Boehringer Ingelheim Investigational Site, Stanford
511.70.01017 Boehringer Ingelheim Investigational Site, Tarzana
511.70.01072 Boehringer Ingelheim Investigational Site, Torrance
511.70.01078 Boehringer Ingelheim Investigational Site, Vista
511.70.01066 Boehringer Ingelheim Investigational Site, Walnut Creek
511.70.01064 Boehringer Ingelheim Investigational Site, Denver
511.70.01001 Boehringer Ingelheim Investigational Site, Wheat Ridge
511.70.01050 Boehringer Ingelheim Investigational Site, Farmington
511.70.01006 Boehringer Ingelheim Investigational Site, Hartford
511.70.01055 Boehringer Ingelheim Investigational Site, New London
511.70.01024 Boehringer Ingelheim Investigational Site, Aventura
511.70.01056 Boehringer Ingelheim Investigational Site, Daytona Beach
511.70.01090 Boehringer Ingelheim Investigational Site, Fort Lauderdale
511.70.01027 Boehringer Ingelheim Investigational Site, Gainesville
511.70.01062 Boehringer Ingelheim Investigational Site, New Port Richey
511.70.01043 Boehringer Ingelheim Investigational Site, Orlando
511.70.01084 Boehringer Ingelheim Investigational Site, Pembroke Pines
511.70.01048 Boehringer Ingelheim Investigational Site, St. Petersburg
511.70.01042 Boehringer Ingelheim Investigational Site, Stuart
511.70.01063 Boehringer Ingelheim Investigational Site, Tampa
511.70.01085 Boehringer Ingelheim Investigational Site, Tampa
511.70.01086 Boehringer Ingelheim Investigational Site, West Palm Beach
511.70.01022 Boehringer Ingelheim Investigational Site, Atlanta
511.70.01057 Boehringer Ingelheim Investigational Site, Atlanta
511.70.01087 Boehringer Ingelheim Investigational Site, Atlanta
511.70.01052 Boehringer Ingelheim Investigational Site, Roswell
511.70.01060 Boehringer Ingelheim Investigational Site, Champaign
511.70.01058 Boehringer Ingelheim Investigational Site, Chicago
511.70.01032 Boehringer Ingelheim Investigational Site, Indianapolis
511.70.01018 Boehringer Ingelheim Investigational Site, Lexington
511.70.01007 Boehringer Ingelheim Investigational Site, Baton Rouge
511.70.01047 Boehringer Ingelheim Investigational Site, New Orleans
511.70.01079 Boehringer Ingelheim Investigational Site, New Orleans
511.70.01031 Boehringer Ingelheim Investigational Site, Saint Louis
511.70.01011 Boehringer Ingelheim Investigational Site, Haverhill
511.70.01028 Boehringer Ingelheim Investigational Site, Detroit
511.70.01081 Boehringer Ingelheim Investigational Site, Detroit
511.70.01082 Boehringer Ingelheim Investigational Site, Billings
511.70.01077 Boehringer Ingelheim Investigational Site, Moorestown
511.70.01019 Boehringer Ingelheim Investigational Site, Endwell
511.70.01076 Boehringer Ingelheim Investigational Site, New York
511.70.01025 Boehringer Ingelheim Investigational Site, Poughkeepsie
511.70.01067 Boehringer Ingelheim Investigational Site, Purchase
511.70.01016 Boehringer Ingelheim Investigational Site, Mount Airy
511.70.01044 Boehringer Ingelheim Investigational Site, Raleigh
511.70.01049 Boehringer Ingelheim Investigational Site, Cincinnati
511.70.01089 Boehringer Ingelheim Investigational Site, Cincinnati
511.70.01054 Boehringer Ingelheim Investigational Site, Columbus
511.70.01075 Boehringer Ingelheim Investigational Site, Dayton
511.70.01002 Boehringer Ingelheim Investigational Site, Mayfield Heights
511.70.01065 Boehringer Ingelheim Investigational Site, Tulsa
511.70.01083 Boehringer Ingelheim Investigational Site, Tulsa
511.70.01036 Boehringer Ingelheim Investigational Site, Medford
511.70.01004 Boehringer Ingelheim Investigational Site, Philadelphia
511.70.01021 Boehringer Ingelheim Investigational Site, West Reading
511.70.01073 Boehringer Ingelheim Investigational Site, Warwick
511.70.01023 Boehringer Ingelheim Investigational Site, Anderson
511.70.01035 Boehringer Ingelheim Investigational Site, Charleston
511.70.01008 Boehringer Ingelheim Investigational Site, Nasville
511.70.01020 Boehringer Ingelheim Investigational Site, Corpus Christi
511.70.01009 Boehringer Ingelheim Investigational Site, Dallas
511.70.01030 Boehringer Ingelheim Investigational Site, Houston
511.70.01091 Boehringer Ingelheim Investigational Site, Houston
511.70.01013 Boehringer Ingelheim Investigational Site, San Antonio
511.70.01005 Boehringer Ingelheim Investigational Site, Salt Lake City
511.70.01061 Boehringer Ingelheim Investigational Site, Sandy City
511.70.01010 Boehringer Ingelheim Investigational Site, Burlington
511.70.01012 Boehringer Ingelheim Investigational Site, Charlottesville
511.70.01046 Boehringer Ingelheim Investigational Site, Norfolk
511.70.01029 Boehringer Ingelheim Investigational Site, Richmond
511.70.01071 Boehringer Ingelheim Investigational Site, Richmond
511.70.01033 Boehringer Ingelheim Investigational Site, Bellevue
511.70.01039 Boehringer Ingelheim Investigational Site, Tacoma
511.70.01069 Boehringer Ingelheim Investigational Site, Milwaukee
Sprout Pharmaceuticals, Inc
INDUSTRY